ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,646
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Efficacy and safety of the novel, long-acting antimuscarinic, aclidinium bromide, in COPD patients in a Phase III study: ACCLAIM/COPD II [abstract]
Author(s):
SI Rennard
,
JF Donohue
,
ED Bateman
,
NJ Gross
,
E Gil
,
C Caracta
Publication date:
2009
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Inflamed lung in vitro co-culture models
Data availability:
ScienceOpen disciplines:
Medicine
,
Respiratory medicine
Comments
Comment on this article
Sign in to comment
Similar content
2,646
Efficacy and safety of twice-daily aclidinium bromide compared with tiotropium and placebo in patients with moderate to severe COPD
Authors:
R. Fuhr
,
H Magnussen
,
A Ribera Llovera
Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD
Authors:
Claus Vogelmeier
,
Pier Luigi Paggiaro
,
Jordi Dorca
…
Overnight deterioration of supine respiratory mechanics in COPD: impact of nocturnal aclidinium bromide/formoterol fumarate
Authors:
N Domnik
,
M James
,
C. Ciavaglia
See all similar